GB Group Ord Shs GBGPF

RE:RE:RE:RE:RE:RE:RE:RE:RE:WOW

[oilcan2012]

Interesting. Trying to quantify your statement???

1. It's logical to think that any firm (WEED) that recieved a license ~three years prior to ACB would be larger, for now. (Hmmm, wonder what happened to CMED?)
2. The 'Big 3' , Canopy, Aphria and Aurora clearly have global aspirations, very focused on being significant contributors to the evolution of marijuana. Stong growth out all of three in a relatively short period. (How does CMED measure up against them?)
3. 'Ethically repugnant' is interesting. So, executing upon their strategy, their investments include a key competitior in the EU; Australia's first licensed producer (Ohhh, and they have an equity gain of ~$65m on this investment; 2 Quebec facilities where utilities are significnatly cheaper and building a huge, technologically advanced grow center in Edmonton that when operational, will lowers costs per gram significantly and shed off over a BILLION $$/y in revenue.  Repugnant? Advocating for global positioning,  being executed by a renowned team, well known throughout the industry? (How is CMED doing? The Michigan investment?  How is that working out?)

The marijuana industry is going to be MASSIVE and firms that are not growing with it will become victims of those firms who get 'strategy and performance'. CMED shareholders have to balance organizational performance against return on capital and WHO can deliver that. Whether is be 38%, 25% or 10%, the CMED Board should be shocked that it was ~36% of shareholders who went to ACB requesting this takeover. 

Of course investing is gambling. We all want a great return, hoping that we get the right cards dealt to us. So, CMED with their performance over ~14 years v ACB in ~3... hmmmm. Newstrike is not even worth mentioning. 

1. Pahria

   MPetersen wrote: I voted no. I don't want to become part of a third place wannabe who can't seem to play well with others. Aurora is behind the 8 ball and is desperate for anything to help them catch up to Canopy and Aphria. Personally, I find ACB management ethically repugnant and completely greed-filled now that they have hit such a high market cap. I'm really hopeful for CMED but greedy investors seem to have lost sight of what investing is... and it's not gambling.